Details for New Drug Application (NDA): 090902
✉ Email this page to a colleague
The generic ingredient in CLINDAMYCIN PALMITATE HYDROCHLORIDE is clindamycin palmitate hydrochloride. There are fifty-five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.
Summary for 090902
| Tradename: | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| Applicant: | Padagis Us |
| Ingredient: | clindamycin palmitate hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 090902
| Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 090902
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLINDAMYCIN PALMITATE HYDROCHLORIDE | clindamycin palmitate hydrochloride | FOR SOLUTION;ORAL | 090902 | ANDA | Bryant Ranch Prepack | 63629-2523 | 63629-2523-1 | 1 BOTTLE, GLASS in 1 CARTON (63629-2523-1) / 100 mL in 1 BOTTLE, GLASS |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | EQ 75MG BASE/5ML | ||||
| Approval Date: | Jul 7, 2010 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
